Troendle August J., PRES, CEO, reported an open-market or private sale at Medpace Holdings, Inc. involving 673.000000 shares for an estimated $417515.74. Reported holdings after the transaction were 544544.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
Form 4 relationship flags and nearby filing context
President & CEO
The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $621.89. The Reporting Person undertakes to provide full pricing information to…
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $620.54. The Reporting Person undertakes to provide full pricing information t…
The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Report…
0 other filings
0 recent txs